Breaking News
Sort by:
Top Post
Novalis Biotech Invests in Ultra Sensitive Genomics Technology by Rarity Bioscience
Rarity Bioscience announces a new strategic investment from Belgium-based Novalis Biotech. The investment is facilitated […]
Mediar Therapeutics Announces $105 Million Financing to Advance Portfolio of First-in-Class Fibrosis Therapies
Mediar Therapeutics, a biotechnology company advancing a portfolio of first-in-class therapies that halt and even […]
Teitur Trophics Raises €28M in Series A Financing to Advance the Development and Treatment for Neurodegenerative Diseases
Teitur Trophics, a biotech company dedicated to developing new treatments for patients suffering from neurodegenerative […]
Ambrx Raises $78 Million and Completes its ATM Program
Ambrx Biopharma today announced that it has completed net sales of approximately $78 million of […]
Allorion Therapeutics Raises $50 Million Series B Financing
Allorion Therapeutics, a biotech company focusing on next-generation precision medicine for oncology and autoimmune diseases, […]
Noema Pharma Raises CHF 103 Million (USD 112 Million) in Series B Financing Round led by Forbion and Jeito Capital
Noema Pharma, a clinical-stage biotech company targeting debilitating central nervous system (CNS) disorders, announced that […]
Prana Thoracic Announces Series A Financing
Prana Thoracic, a medical device company developing the first minimally invasive lung tissue excision tool […]
Chroma Medicine Secures $135M in Series B Financing to Advance Breakthrough Epigenetic Editing Technology
Chroma Medicine, a genomic medicine company pioneering single-dose epigenetic editing therapeutics, today announced the completion […]
Antiverse Raises Funding and Demonstrates Therapeutic Antibody Identification with AI-driven Drug Discovery Platform
Antiverse Ltd, a biotechnology company developing a computational antibody drug discovery platform, has announced the […]
Oricell Closes $45M Series B1 Financing to Expand Development of Key Products
Oricell Therapeutics, a China-based innovative pharmaceutical company committed to the development of tumor cellular immunotherapeutics, […]
Eluminex Biosciences Closes $40+ Million Series B Financing
Eluminex Biosciences has officially announced the closing of a Series B financing of over $40 […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more